Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Jan;32(1):87-93.
doi: 10.1007/s00192-019-04193-4. Epub 2020 Feb 3.

Exploratory analysis of the effect of mirabegron on urodynamic sensation parameters and urethral pressure variations

Maxime T M Kummeling  1 , Joost Egberts  2 , Henk W Elzevier  2 , Gommert A van Koeveringe  3 , Hein Putter  4 , Pieter M Groenendijk  5
Affiliations

Exploratory analysis of the effect of mirabegron on urodynamic sensation parameters and urethral pressure variations

Maxime T M Kummeling et al. Int Urogynecol J. 2021 Jan.

Abstract

Introduction and hypothesis: Urethral instability (URI) has in the past been defined by the International Continence Society (ICS), but was excluded from ICS terminology and definitions shortly after because of a lack of consensus about the clinical importance of this phenomenon. Recently, interest in URI and its possible role in overactive bladder (OAB) increased again. In the last decade, a beta 3 adrenoreceptor agonist (mirabegron) was approved for the treatment of OAB. The effect of mirabegron on urethral pressure during filling cystometry is unknown. The aim of this study was to assess the influence of mirabegron on urethral pressure variations during urodynamic investigation and the association of symptoms and voiding diary data before and during treatment.

Methods: This prospective study included 51 consecutive adult female patients, referred with OAB. Patients were evaluated using a voiding diary, two validated questionnaires and two urodynamic investigations, one before and one after 6 weeks of treatment with mirabegron. URI was defined as an urethral pressure drop exceeding 30 cmH2O during filling cystometry.

Results: The prevalence of URI was 31% at initial urodynamic investigation, and 19% at second investigation. URI is more common than DO with 18% prevalence at initial evaluation. Treatment with mirabegron resulted in significant changes in symptoms and urodynamic sensory markers in patients with URI.

Conclusion: Urethral pressure variations are significantly reduced by treatment with mirabegron in patients with URI. URI seems to have a predictive value in treatment choices for OAB. Future research should elucidate this.

Keywords: Female; Mirabegron; Overactive bladder; Urethral pressure; Urodynamics.

PubMed Disclaimer

References

    1. De Groat WC, Griffiths D, Yoshimura N. Neural control of the lower urinary tract. Compr Physiol. 2015;5(1):327–96. - PubMed - PMC
    1. Abrams P, Cardozo L, Fall M, Griffiths D, Rosier P, Ulmsten U, et al. The standardisation of terminology in lower urinary tract function: report from the standardisation sub-committee of the International Continence Society. Urology. 2003;61(1):37–49. - PubMed
    1. Lagro-Janssen T, Smits A, Van Weel C. Urinary incontinence in women and the effects on their lives. Scand J Prim Health Care. 1992;10(3):211–6. - PubMed
    1. Diokno AC. Epidemiology and psychosocial aspects of incontinence. Urol Clin North Am. 1995;22(3):481–5. - PubMed
    1. Dmochowski RR, Newman DK. Impact of overactive bladder on women in the United States: results of a national survey. Curr Med Res Opin. 2007;23(1):65–76. - PubMed

LinkOut - more resources